Characteristics of sars-coV-2 and covid-19

20, 411–412 (2020).
113
. To, K. K. et al. Consistent detection of 2019 novel 
coronavirus in saliva. Clin. Infect. Dis. 71, 841–843 
(2020).
114
. Wang, W. et al. Detection of SARS- CoV-2 in different 
types of clinical specimens. JAMA 323, 1843–1844 
(2020).
115
. Han, H., Luo, Q., Mo, F., Long, L. & Zheng, W. 
SARS-CoV-2 RNA more readily detected in induced 
sputum than in throat swabs of convalescent
COVID-19 patients. Lancet Infect. Dis. 20, 655–656 
(2020).
116
. Zhang, W. et al. Molecular and serological 
investigation of 2019-nCoV infected patients: 
implication of multiple shedding routes. Emerg. 
Microbes Infect.
9, 386–389 (2020).
117
. Li, T. Diagnosis and clinical management of
severe acute respiratory syndrome coronavirus 2 
(SARS- CoV-2) infection: an operational recommen-
dation of Peking Union Medical College Hospital 
(V2.0). Emerg. Microbes Infect. 9, 582–585 (2020).
118
. Xie, X. et al. Chest CT for typical 2019-nCoV 
pneumonia: relationship to negative RT- PCR testing. 
Radiology
296, E41–E45 (2020).
119
. Kanne, J. P. & Chest, C. T. Findings in 2019 novel 
coronavirus (2019-nCoV) infections from Wuhan, 
China: key points for the radiologist. Radiology 295, 
16–17 (2020).
120
. Guo, L. et al. Profiling early humoral response to 
diagnose novel coronavirus disease (COVID-19).
Clin. Infect. Dis.
71, 778–785 (2020).
121
. To, K. K. et al. Temporal profiles of viral load in 
posterior oropharyngeal saliva samples and serum 
antibody responses during infection by SARS- CoV-2: 
an observational cohort study. Lancet Infect. Dis. 20, 
565–574 (2020).
122
. Wang, X. et al. The anti- influenza virus drug, arbidol is 
an efficient inhibitor of SARS- CoV-2 in vitro. Cell Discov.